5-(Pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine

Introduction

CAS No. :	918511-92-9	MDL No. :	MFCD18206955
Formula :	C12H9N3	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	JGBIBMXDDURRQW-UHFFFAOYSA-N
M.W :	195.22	Pubchem ID :	51358551
Synonyms :

Physicochemical Properties

Num. heavy atoms :	15
Num. arom. heavy atoms :	15
Fraction Csp3 :	0.0
Num. rotatable bonds :	1
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	59.32
TPSA :	41.57 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	Yes
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-6.16 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.63
Log Po/w (XLOGP3) :	1.87
Log Po/w (WLOGP) :	2.62
Log Po/w (MLOGP) :	1.39
Log Po/w (SILICOS-IT) :	3.06
Consensus Log Po/w :	2.11

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.9
Solubility :	0.244 mg/ml ; 0.00125 mol/l
Class :	Soluble
Log S (Ali) :	-2.36
Solubility :	0.843 mg/ml ; 0.00432 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-5.06
Solubility :	0.0017 mg/ml ; 0.00000873 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.94

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P305+P351+P338	UN#:
Hazard Statements:	H302-H315-H319-H335	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine